During an inspection of compliance with Chinese GMO rules which the Ministry carried out throughout China, it was reported that the vast majority of inspected units complied but seven R & D units and test units did irregular reporting. For example, Beijing Huaxin...
The Hebei-based company is the only one in China which commercially uses three expression systems (mammalian cells, recombinant yeast, Escherichia coli). They are a leading producer of hepatitis B vaccine, G-CSF, GM-CSF, EPO and are the country’s major producer...
The group around LIU Guang-Hui at Tongji University in Shanghai has expanded airway basal cells isolated from bronchodilator patients collected at the time of bronchoscopy. After expansion and implantation in the donor patient, pulmonary functions improved. Nikkei...
According to the National Bureau of Statistics, R&D spending rose 11.6 percent year-on-year to 1.75 trillion yuan (about 280 billion U.S. dollars) in 2017. The spending accounted for 2.12 percent of China’s gross domestic product. Chinese enterprises spent...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.